These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 12657283)
1. Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potency. Gwaltney SL; O'Connor SJ; Nelson LT; Sullivan GM; Imade H; Wang W; Hasvold L; Li Q; Cohen J; Gu WZ; Tahir SK; Bauch J; Marsh K; Ng SC; Frost DJ; Zhang H; Muchmore S; Jakob CG; Stoll V; Hutchins C; Rosenberg SH; Sham HL Bioorg Med Chem Lett; 2003 Apr; 13(7):1363-6. PubMed ID: 12657283 [TBL] [Abstract][Full Text] [Related]
2. Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives. Gwaltney SL; O'Connor SJ; Nelson LT; Sullivan GM; Imade H; Wang W; Hasvold L; Li Q; Cohen J; Gu WZ; Tahir SK; Bauch J; Marsh K; Ng SC; Frost DJ; Zhang H; Muchmore S; Jakob CG; Stoll V; Hutchins C; Rosenberg SH; Sham HL Bioorg Med Chem Lett; 2003 Apr; 13(7):1359-62. PubMed ID: 12657282 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of conformationally constrained 5,6,7, 8-Tetrahydroimidazo[1,5-a]pyridine inhibitors of farnesyltransferase. Dinsmore CJ; Zartman CB; Baginsky WF; O'Neill TJ; Koblan KS; Chen IW; McLoughlin DA; Olah TV; Huff JR Org Lett; 2000 Nov; 2(22):3473-6. PubMed ID: 11082012 [TBL] [Abstract][Full Text] [Related]
4. Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase. Curtin ML; Florjancic AS; Cohen J; Gu WZ; Frost DJ; Muchmore SW; Sham HL Bioorg Med Chem Lett; 2003 Apr; 13(7):1367-71. PubMed ID: 12657284 [TBL] [Abstract][Full Text] [Related]
5. Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailability. Tong Y; Lin NH; Wang L; Hasvold L; Wang W; Leonard N; Li T; Li Q; Cohen J; Gu WZ; Zhang H; Stoll V; Bauch J; Marsh K; Rosenberg SH; Sham HL Bioorg Med Chem Lett; 2003 May; 13(9):1571-4. PubMed ID: 12699757 [TBL] [Abstract][Full Text] [Related]
6. Pyridone-containing farnesyltransferase inhibitors: synthesis and biological evaluation. Hasvold LA; Wang W; Gwaltney SL; Rockway TW; Nelson LT; Mantei RA; Fakhoury SA; Sullivan GM; Li Q; Lin NH; Wang L; Zhang H; Cohen J; Gu WZ; Marsh K; Bauch J; Rosenberg S; Sham HL Bioorg Med Chem Lett; 2003 Nov; 13(22):4001-5. PubMed ID: 14592494 [TBL] [Abstract][Full Text] [Related]
7. Oxo-piperazine derivatives of N-arylpiperazinones as inhibitors of farnesyltransferase. Dinsmore CJ; Bergman JM; Wei DD; Zartman CB; Davide JP; Greenberg IB; Liu D; O'Neill TJ; Gibbs JB; Koblan KS; Kohl NE; Lobell RB; Chen IW; McLoughlin DA; Olah TV; Graham SL; Hartman GD; Williams TM Bioorg Med Chem Lett; 2001 Feb; 11(4):537-40. PubMed ID: 11229765 [TBL] [Abstract][Full Text] [Related]
8. Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase. Augeri DJ; O'Connor SJ; Janowick D; Szczepankiewicz B; Sullivan G; Larsen J; Kalvin D; Cohen J; Devine E; Zhang H; Cherian S; Saeed B; Ng SC; Rosenberg S J Med Chem; 1998 Oct; 41(22):4288-300. PubMed ID: 9784104 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors. Lombardo LJ; Camuso A; Clark J; Fager K; Gullo-Brown J; Hunt JT; Inigo I; Kan D; Koplowitz B; Lee F; McGlinchey K; Qian L; Ricca C; Rovnyak G; Traeger S; Tokarski J; Williams DK; Wu LI; Zhao Y; Manne V; Bhide RS Bioorg Med Chem Lett; 2005 Apr; 15(7):1895-9. PubMed ID: 15780629 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of 1H-pyridin-2-one derivatives as potent and selective farnesyltransferase inhibitors. Wang L; Lin NH; Li Q; Henry RF; Zhang H; Cohen J; Gu WZ; Marsh KC; Bauch JL; Rosenberg SH; Sham HL Bioorg Med Chem Lett; 2004 Sep; 14(18):4603-6. PubMed ID: 15324873 [TBL] [Abstract][Full Text] [Related]
11. Potent, non-thiol inhibitors of farnesyltransferase. Breslin MJ; deSolms SJ; Giuliani EA; Stokker GE; Graham SL; Pompliano DL; Mosser SD; Hamilton KA; Hutchinson JH Bioorg Med Chem Lett; 1998 Dec; 8(23):3311-6. PubMed ID: 9873725 [TBL] [Abstract][Full Text] [Related]
12. 3-Aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency. Bell IM; Gallicchio SN; Abrams M; Beese LS; Beshore DC; Bhimnathwala H; Bogusky MJ; Buser CA; Culberson JC; Davide J; Ellis-Hutchings M; Fernandes C; Gibbs JB; Graham SL; Hamilton KA; Hartman GD; Heimbrook DC; Homnick CF; Huber HE; Huff JR; Kassahun K; Koblan KS; Kohl NE; Lobell RB; Lynch JJ; Robinson R; Rodrigues AD; Taylor JS; Walsh ES; Williams TM; Zartman CB J Med Chem; 2002 Jun; 45(12):2388-409. PubMed ID: 12036349 [TBL] [Abstract][Full Text] [Related]
13. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by 5-cinnamoylaminobenzophenones. Mitsch A; Wissner P; Böhm M; Silber K; Klebe G; Sattler I; Schlitzer M Arch Pharm (Weinheim); 2004 Sep; 337(9):493-501. PubMed ID: 15362122 [TBL] [Abstract][Full Text] [Related]
14. Non-thiol farnesyltransferase inhibitors: utilization of the near aryl binding site by 5-arylacetylaminobenzophenones. Mitsch A; Böhm M; Sattler I; Schlitzer M Arch Pharm (Weinheim); 2004 Apr; 337(4):213-8. PubMed ID: 15065081 [TBL] [Abstract][Full Text] [Related]